Breaking News
12 hours ago
Simantini Singh Deo

ModernaTX secures FDA biologics licensure for MNEXSPIKE under STN 125835, with a layered approval record spanning May–September 2025.
Simantini Singh Deo

Steps Biosciences and RDGVRP open a Bengaluru R&D centre targeting sterile injectables and complex drug delivery systems.
Vaibhavi M.

Alembic Pharmaceuticals appoints Ramesh Juneja as EVP, Human Health, sharpening domestic commercial leadership amid growing GMP and supply scrutiny.
Vaibhavi M.

ResMed acquires Noctrix Health for $340 million, expanding into neuromuscular sleep therapy and triggering QMS integration work.
Vaibhavi M.
